Literature DB >> 6174210

Characterization of high- and low-metastatic clones derived from a methylcholanthrene-induced murine fibrosarcoma.

N Wang, S H Yu, I E Liener, R P Hebbel, J W Eaton, C F McKhann.   

Abstract

A methylcholanthrene-induced fibrosarcoma (3AM) and several of its clones were evaluated for pulmonary metastasis, growth rate, and chromosome composition. Heterogeneity was observed in the three parameters, and no correlation was found between growth rate and metastatic potential. Furthermore, three clones (10, 34, and 27) were identified with distinctive, high or low, metastatic potential and marker chromosomes. The marker chromosomes characteristic for each clone were identified in the early passages of the parental 3AM line, indicating the preexistence of the different cell types in the original neoplasm. The three clones were then characterized as to tendency to adhere to vascular endothelium, immunogenicity, and antigenic specificity. Clone 10, with two large metacentric markers (T2, 4 and T10, 15) and the highest metastatic potential (221 foci/lung), expressed the highest endothelial attachment and immunogenicity. Clone 27 was characterized with an extremely low rate of metastasis (nine foci/lung) and a T2, 7 large acrocentric marker, while clone 34 was characterized with a moderate rate of metastasis (107.5 foci/lung) and a T4, 16 acrocentric marker. Antigenically, clone 10 cross-reacted with clones 34 and 27 and 3AM, while clones 27 and 34 cross-reacted with clone 10 and 3AM but not with each other, suggesting that, within the original tumor, there were common tumor antigens shared by some cells but no universal antigen shared by all cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174210

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Expression of a specific protein in spontaneously metastatic fibrosarcoma cell lines and its enhanced synthesis by growth on laminin or fibronectin.

Authors:  J H Youngblom; N Wang; J B McCarthy; M Janatipour; T Wang; J R Sheppard; S S Panter
Journal:  Clin Exp Metastasis       Date:  1990 Jan-Feb       Impact factor: 5.150

2.  Biological heterogeneity and radiation sensitivity of in vitro propagated lung metastatic lines originated from a transplantable squamous cell carcinoma of BALB/c mouse.

Authors:  R J Jamasbi; E H Perkins
Journal:  In Vitro Cell Dev Biol       Date:  1990-03

Review 3.  Implications of tumor progression on clinical oncology.

Authors:  D R Welch; S P Tomasovic
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

4.  Proteolytic and metastatic activities of clones derived from a methylcholanthrene-induced murine fibrosarcoma.

Authors:  M E McLaughlin; I E Liener; N Wang
Journal:  Clin Exp Metastasis       Date:  1983 Oct-Dec       Impact factor: 5.150

5.  Tumor heterogeneity: biological implications and therapeutic consequences.

Authors:  G H Heppner; B E Miller
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

6.  Mechanism of liver-specific metastatic tumor spread in a murine tumor model.

Authors:  G Edel
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

7.  Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases.

Authors:  G Poste; J Tzeng; J Doll; R Greig; D Rieman; I Zeidman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  Isolation and characterization of low- and high-metastatic clones from murine RCT (Radiological, Chiba, and Toyama) sarcoma.

Authors:  H Matsui; S Tatezaki; H Tsuji; H Ochiai
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

Review 9.  Intratumor immunologic heterogeneity.

Authors:  F R Miller
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

Review 10.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.